CTLA4 and neoplasm: Furthermore, the intratumoral introduction of rAd.sT in the immunocompetent breast cancer mice model impeded tumor progression and metastasis in lungs and liver synergistically with anti-CTLA-4 and anti-PD-1 antibodies [55].